CORTESI PAOLO ANGELO

Fornari, C., Antonacci, S., Stoppa, S., Mantovani, L., Castaman, G., Cortesi, P. (2026). Economic Implication of Targeting Higher Trough Level with Extended Half-Life FVIII Prophylaxis. FARMECONOMIA E PERCORSI TERAPEUTICI, 27(1), 13-20 [10.7175/fe.v27i1.1604]. Dettaglio

Zamagni, G., Armocida, B., Castelpietra, G., Conti, S., Cortesi, P., Ferrara, P., et al. (2026). Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 67-77 [10.19191/EP26.1.A991.020]. Dettaglio

Cortesi, P., Mezghani, M., Alshaikheid, M., Lunk, I., D'Orsi, M., Zurria, M., et al. (2026). Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison. ADVANCES IN THERAPY [10.1007/s12325-026-03553-z]. Dettaglio

Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Dettaglio

Antonazzo, I., Fornari, C., Zamparini, M., Crotti, G., Zucchi, A., Ferrara, P., et al. (2026). Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study. FRONTIERS IN PHARMACOLOGY, 17 [10.3389/fphar.2026.1708009]. Dettaglio